Report of Foreign Issuer (6-k)
October 09 2018 - 7:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2018
Commission File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s
name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____
EXPLANATORY NOTE
Medigus Ltd.
hereby furnishes herewith as exhibit 99.1 a letter to the shareholders on behalf of the board of directors.
WARNING CONCERNING FORWARD LOOKING STATEMENTS
This Report of Foreign
Private Issuer on Form 6-K contains statements which constitute forward looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 and other securities laws. These forward looking statements are based upon the Company’s present
intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons,
including some reasons which are beyond the Company’s control. For this reason, among others, you should not place undue
reliance upon the Company’s forward looking statements. Except as required by law, the Company undertakes no obligation to
revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of
this Report.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: October 9, 2018
|
By:
|
/s/ Oded Yatzkan
|
|
|
Oded Yatzkan
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024